Company Filing History:
1 out of 3 
1 out of 2 
1 out of 1 Years Active: 2017
Title: Weronika Jonko: Innovator in Cancer Treatment
Introduction
Weronika Jonko is a prominent inventor based in Warsaw, Poland. She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic agents. Her work focuses on the selection of hDIS3 PIN domain inhibitors, which hold promise for treating various cancers.
Latest Patents
Weronika Jonko holds 1 patent for her invention titled "Method for selection of hDIS3 PIN domain inhibitors and use of hDIS3 PIN domain inhibitors for cancer treatment." This invention relates to a method for screening hDIS3 PIN domain inhibitors, as well as the yeast strain and cell line used in such methods. It also introduces new therapeutic agents selected as hDIS3 PIN domain inhibitors and their applications in treating cancers with mutations in the hDIS3 RNB domain, particularly multiple myeloma. Additionally, the invention encompasses a composition comprising the new therapeutic agent hDIS3 PIN domain inhibitor and a method for inducing synthetic lethality in cancer cells.
Career Highlights
Throughout her career, Weronika Jonko has worked with esteemed organizations, including the Institute of Biochemistry and Biophysics of the Polish Academy of Sciences and Oncoarendi Therapeutics Sp. z o.o. Her research has been pivotal in advancing the understanding of cancer treatment methodologies.
Collaborations
Weronika has collaborated with notable colleagues such as Andrzej Dziembowski and Rafal Tomecki, contributing to the collective effort in cancer research and innovation.
Conclusion
Weronika Jonko's contributions to cancer treatment through her innovative patent and collaborative efforts highlight her role as a leading inventor in the field. Her work continues to inspire advancements in therapeutic strategies for cancer patients.